MoneyWorks4Me

Concord Drugs informs about certificate

20 Jan 2024 Evaluate

Concord Drugs has informed that it enclosed Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31.12.2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1741.60
Dr. Reddys Labs. 1222.80
Cipla 1326.90
Lupin 1914.75
Zydus Lifesciences 1124.50
View more..